T1	Condition 6 22	hypersensitivity
T2	Drug 26 37	paracetamol
T3	Drug 41 49	mannitol
*	OR T2 T3
T4	Non-representable 50 79	(excipient with known effect)
T5	Scope 26 49	paracetamol or mannitol
R1	Has_scope Arg1:T1 Arg2:T5	
T6	Condition 88 116	hepatocellular insufficiency
T7	Measurement 118 122	ASAT
T8	Measurement 126 130	ALAT
T9	Value 131 135	> 5N
*	OR T7 T8 T11
T11	Measurement 140 149	bilirubin
T12	Value 150 154	> 2N
R2	Has_value Arg1:T11 Arg2:T12	
R3	Has_value Arg1:T8 Arg2:T9	
R4	Has_value Arg1:T7 Arg2:T9	
T10	Scope 118 154	ASAT or ALAT > 5N, or bilirubin > 2N
R5	Subsumes Arg1:T6 Arg2:T10	
T13	Procedure 157 185	Pharmacological intervention
T14	Drug 157 172	Pharmacological
R6	multi Arg1:T13 Arg2:T14	
T15	Drug 205 220	corticosteroids
T16	Drug 222 228	NSAIDs
T17	Drug 232 243	paracetamol
*	OR T16 T17 T15
T18	Scope 205 243	corticosteroids, NSAIDs or paracetamol
T19	Procedure 248 269	physical intervention
T20	Procedure 271 297	external cooling technique
T21	Qualifier 299 329	that may influence temperature
T22	Temporal 330 349	in the last 6 hours
R7	Subsumes Arg1:T19 Arg2:T20	
R8	Has_scope Arg1:T13 Arg2:T18	
*	OR T13 T19
T23	Scope 157 298	Pharmacological intervention (administration of corticosteroids, NSAIDs or paracetamol) or physical intervention (external cooling technique)
R9	Has_qualifier Arg1:T23 Arg2:T21	
R10	Has_temporal Arg1:T23 Arg2:T22	
T24	Measurement 318 329	temperature
R11	multi Arg1:T21 Arg2:T24	
T25	Condition 352 360	Pregnant
T26	Observation 364 377	breastfeeding
*	OR T26 T25
T27	Person 378 383	women
T28	Competing_trial 385 421	Previous participation in this study
